Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease eosinophilia
Phenotype C0015230|rash
Sentences 147
PubMedID- 20103499 Drug rash with eosinophilia and systemic symptoms (dress): changing carbamazepine to phenobarbital controlled epilepsy without the recurrence of dress.
PubMedID- 22611746 Drug rash with eosinophilia and systemic symptoms (dress syndrome).
PubMedID- 22224158 Severe cutaneous drug eruption encompasses blistering drug eruptions not meeting criteria for emm/sjs, including lithium hypersensitivity syndrome, phenytoin hypersensitivity syndrome, and drug rash with eosinophilia and systemic symptoms.
PubMedID- 20358026 Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and stevens-johnson syndrome.
PubMedID- 23774556 Dress (drug rash with eosinophilia and systemic symptoms) syndrome is a severe reaction triggered by drugs that manifests as pyrexia and eosinophilia with involvement of the skin and internal organs.
PubMedID- 24749495 Abbreviations: ap, anaphylactoid purpura; dihs, drug‐induced hypersensitivity syndrome; dress, drug rash with eosinophilia and systemic symptoms; e/d, eczema/dermatitis; sjs, stevens–johnson syndrome; ten, toxic epidermal necrolysis.
PubMedID- 26418832 The third case of vemurafenib-induced drug rash with eosinophilia and systemic symptoms (dress) syndrome is reported herein.
PubMedID- 20571998 Dress syndrome (drug reaction or rash with eosinophilia and systemic symptoms)].
PubMedID- 24509972 Herein, we report two cases of drug rash with eosinophilia and systemic symptoms (dress) secondary to telaprevir use.
PubMedID- 22707770 Ceftriaxone induced dress case has been supported by a turkish case report informing about dress like severe drug rash with eosinophilia, atypical lymphocytosis and fever secondary to ceftriaxone.
PubMedID- 24016284 Drug rash with eosinophilia and systemic symptoms (dress) is a severe drug-induced hypersensitivity syndrome that presents with diffuse cutaneous eruptions, fever, and multiorgan involvement.
PubMedID- 24757661 Drug rash with eosinophilia and systemic symptoms (dress) syndrome is an extremely serious adverse effect caused by medications, characterized by skin rash, fever, and lymphadenopathy.
PubMedID- 20190474 Drug rash with eosinophilia and systemic symptoms (dress), also known as drug-induced hypersensitivity syndrome (dihs), is a severe adverse drug reaction affecting multiple organs caused by drug treatment.
PubMedID- 23248384 The syndrome is commonly referred to as either drug rash with eosinophilia and systemic symptoms (dress) or dhs.
PubMedID- 20843501 Drug rash with eosinophilia and systemic symptoms syndrome associated with clindamycin.
PubMedID- 22511907 Drug rash with eosinophilia and systemic symptoms (dress) syndrome is a severe, drug-induced hypersensitivity reaction characterized by skin rash, fever, lymph-node enlargement, and internal organ involvement.
PubMedID- 20653681 Hypersensitivity to amoxicillin after drug rash with eosinophilia and systemic symptoms (dress) to carbamazepine and allopurinol: a possible co-sensitization.
PubMedID- 24687387 However, severe cutaneous adverse drug reactions have been reported, such as drug rash with eosinophilia and systemic symptoms (dress), stevens-johnson syndrome (sjs), and toxic epidermal necrolysis (ten).
PubMedID- 24337150 A dress syndrome (drug rash with eosinophilia and systemic symptoms) was confirmed in accordance with the diagnostic criteria.
PubMedID- 22345792 To better individualize this drug reaction, the term, drug rash with eosinophilia and systemic symptoms (dress) syndrome” has recently been used.
PubMedID- 25981739 Possible drug rash with eosinophilia and systemic symptoms (dress) syndrome cases were identified and manually validated.
PubMedID- 25593801 Imatinib causing drug rash with eosinophilia and systemic symptoms: a rare cutaneous reaction.
PubMedID- 23141052 Background: drug-induced hypersensitivity syndrome (dihs)/drug rash with eosinophilia and systemic symptoms (dress) is a serious acute drug reaction with fever, cutaneous eruption, lymphadenopathy, and several visceral dysfunctions.
PubMedID- 22271506 A case of drug rash with eosinophilia and systemic symptoms (dress) syndrome complicating airway management.
PubMedID- 23741237 Drug rash with eosinophilia and systemic symptoms (dress) syndrome is characterized by a severe idiosyncratic reaction including rash and fever, often with associated hepatitis, arthralgias, lymph node enlargement, or hematologic abnormalities.
PubMedID- 23521335 Another striking example is a case of dress (drug rash with eosinophilia and systemic symptoms) presented by bernez et al.[10].
PubMedID- 23341990 Previously unreported aes like drug rash with eosinophilia and systemic symptoms (dress), granulomatous inflammation of the central nervous system, and aseptic meningitis, were documented.
PubMedID- 21738885 Less frequently, vasculitis, anaphylaxis,4 ototoxicity, neutropenia, fixed drug eruptions, fever, phlebitis, nephrotoxicity,5 thrombocytopenia,6 and, more rarely, stevens-johnson or drug rash with eosinophilia and systemic symptoms (dress) syndrome have been reported.7 a recent study conducted at six korean pharmacovigilance centers (pvcs) reported that antibiotics including vancomycin were the most prevalent causes of adrs, and that skin manifestations were the most common symptoms in spontaneously reported adrs.8 of the 1,418 cases in the study, 3.1% were associated with vancomycin.
PubMedID- 24175948 However, other immunologic drug reactions have been reported including anaphylactic shock, urticaria, angioedema, fixed drug eruptions, bullous eruptions, agep, sweet’s syndrome, sjs, and dihs/drug rash with eosinophilia and systemic symptoms (dress) [54–61].
PubMedID- 24014920 Nevirapine-induced rash with eosinophilia and systemic symptoms (dress).
PubMedID- 20136879 Its value in drug rash with eosinophilia and systemic symptoms (dress) has not been established in a large cohort of patients.
PubMedID- 24479051 [1] since then it has been known as drug hypersensitivity syndrome and is now more often referred to as dress syndrome, when it involves a case of “drug rash with eosinophilia and systemic symptoms.”[12] dress syndrome is a specific, severe, idiosyncratic drug reaction characterized by a skin rash with fever, facial edema, lymphadenopathy, and visceral involvement (hepatitis, pneumonitis, myocarditis, nephritis, and colitis).
PubMedID- 23165860 Fatal clindamycin-induced drug rash with eosinophilia and systemic symptoms (dress) syndrome.
PubMedID- 22525393 The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (dress) syndrome.
PubMedID- 23734933 In the t12/pr24 group, however, two cases of stevens-johnson syndrome and one case of drug rash with eosinophilia and systemic symptoms, which corresponds to drug-induced hypersensitivity syndrome in japan, were reported.
PubMedID- 25372334 Conclusion: drug reaction (or rash) with eosinophilia and systemic symptoms syndrome can present as cutaneous rash, mucosal lesions, eosinophilia, intermediate uveitis, and intraretinal hemorrhages.
PubMedID- 25422656 The severe types (sjs, ten, drug rash with eosinophilia and systemic symptoms and overlap syndrome) were more frequent in the patients aged
PubMedID- 23723550 Cases of severe cutaneous adverse reactions including erythema multiforme, stevens–johnson syndrome, toxic epidermal necrolysis, and drug rash with eosinophilia and systemic symptoms involving adult and pediatric patients have been received by fda.
PubMedID- 23575622 Cases description: we report two cases of drug rash with eosinophilia and systemic symptoms (dress) associated with the use of carbamazepine and phenytoin in brazilian boys tested for human leukocyte antigen (hla) class i and ii alleles.
PubMedID- 22371734 Drug rash with eosinophilia and systemic symptoms (dress) is a multisystemic disorder resulting from reaction to certain drugs, especially anticonvulsants, but also sulfonamides, minocycline, allopurinol and others.
PubMedID- 25282350 The following entities are of special importance: stevens johnson syndrome (sjs), toxic epidermal necrolysis (ten), acute generalized exanthematous pustulosis (agep) and drug rash with eosinophilia and systemic symptoms (dress).
PubMedID- 26438676 Drug rash with eosinophilia and systemic symptoms (dress) syndrome is characterised by fever, rash, eosinophilia and organ damage that develops 2-6 weeks after the initiation of a medication.
PubMedID- 20480148 No cases of onj, stevens–johnson syndrome, or drug rash with eosinophilia and systemic symptoms were found.
PubMedID- 23248415 Drug rash with eosinophilia and systemic symptoms (dress) syndrome is a rare and life-threatening delayed drug hypersensitivity reaction characterized by skin eruption, fever, lymphadenopathies, and visceral involvement.
PubMedID- 25630796 Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
PubMedID- 21361742 The life-threatening dress (drug rash with eosinophilia and systemic symptoms) syndrome is characterized by the presence of at least three of the following findings: fever, exanthema, eosinophilia, atypical circulating lymphocytes, lymphadenopathy, and hepatitis.
PubMedID- 21951554 Drug rash with eosinophilia and systemic symptoms (dress) is a severe cutaneous drug reaction.
PubMedID- 24133560 Background: drug rash with eosinophilia and systemic symptoms (dress) is a severe drug reaction characterised by rash, eosinophilia and systemic involvement.
PubMedID- 23882307 It has been described using many terms; however, drug rash with eosinophilia and systemic symptoms syndrome appears to be the most appropriate.
PubMedID- 24843805 Drug rash with eosinophilia and systemic symptoms syndrome induced by chloral hydrate in early childhood.

Page: 1 2 3